K(+) channels as therapeutic targets in oncology

Walter Stühmer1, Luis A Pardo

  • 1Department of Molecular Biology of Neuronal Signals, Max-Planck Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Göttingen, Germany. ws@em.mpg.de

Insights

Potassium channels are abnormally expressed in many cancers, and targeting them can impair tumor progression. Research explores various strategies, including small molecules and gene therapy, for therapeutic intervention in cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Ion channels play a role in various tumors.
  • Abnormal potassium channel expression is observed in numerous cancer types.
  • Pharmacological targeting of potassium channels can impede tumor progression.

Purpose of the Study:

  • To review the role of potassium channels in cancer.
  • To discuss the therapeutic potential of targeting potassium channels in oncology.
  • To explore future developments in potassium channel-targeted cancer therapies.

Main Methods:

  • Review of existing literature on potassium channels in cancer.
  • Analysis of pharmacological strategies for potassium channel manipulation.
  • Exploration of gene therapy and adjuvant therapy approaches.

Main Results:

  • Potassium channels are viable therapeutic targets in cancer.
  • A significant body of knowledge exists regarding potassium channel pharmacology.
  • Various therapeutic strategies are proposed, including small molecule inhibitors and gene therapy.

Conclusions:

  • Potassium channels represent promising targets for cancer therapy.
  • Further research into potassium channel modulation could lead to novel cancer treatments.
  • The development of targeted therapies holds potential for improving cancer patient outcomes.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...